Serum Immunoglobulin Levels in Splenectomized and Non-Splenectomized Patients with Major Beta-Thalassemia

被引:0
作者
Kiani-amin, Mojgan [1 ]
Daneshi, Mohammadmehdi [1 ]
Ayazi, Parviz [1 ]
Mohammadian, Shima [1 ]
Rezaei, Nima [2 ,3 ]
机构
[1] Qazvin Univ Med Sci, Qods Hosp, Qazvin, Iran
[2] Univ Tehran Med Sci, Mol Immunol Res Ctr, Dept Immunol, Sch Med, Tehran, Iran
[3] Childrens Med Ctr, Res Ctr Immunodeficiencies, Tehran, Iran
关键词
Humoral Immune System; Immunoglobulins; Major Beta-Thalassemia; Splenectomy; ABNORMALITIES; CHILDREN; PROFILE;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective: Thalassemia is a common disease in many countries, in which several complications such as infections can occur. Although aberration in the function of the immune system could be a reason for such complication, a little is known about the status of humoral immune system in major beta thalassemia. In this study we measured serum immunoglobulins level in a group of patients with major beta thalassemia. Methods: Ninety nine patients with major beta thalassemia were enrolled in this study divided into two groups of splenctomized and not splenctomized patients. Serum IgG, IgM and IgA levels of these patients were measured and analyzed. Findings: Serum mean levels of IgG and IgM in patients of all ages in both groups were normal. The mean serum IgA level in the group of not splenectomized patients aged less than five years as well as in the splenectomized patients aged more than twenty years was increased. However, it was normal in other age groups. Conclusion: Although this study could not show any defect in the humoral immune system, evaluation of immunoglobulins could be useful to understand the relmarkable high rate of infection in the patients with major beta thalassemia.
引用
收藏
页码:95 / 98
页数:4
相关论文
共 12 条
[1]   Immune functions in splenectomized thalassaemic children [J].
Ahluwalia J. ;
Datta U. ;
Marwaha R.K. ;
Sehgal S. .
The Indian Journal of Pediatrics, 2000, 67 (12) :871-876
[2]  
AKBAR AN, 1985, CLIN EXP IMMUNOL, V62, P397
[3]  
Amin A., 2005, IranJImmunol, V2, P220
[4]  
Cao A, 2010, GENET MED, V12, P61, DOI [10.1097/GIM.0b013e3181cd68ed, 10.1038/gim.2016.173]
[5]  
DWYER J, 1987, CLIN EXP IMMUNOL, V68, P621
[6]  
Farmakis D, 2003, MED SCI MONITOR, V9, pRA19
[7]   Immune function in patients with beta thalassaemia receiving the orally active iron-chelating agent deferiprone [J].
Loebstein, R ;
Dalal, I ;
NisbetBrown, E ;
Berkovitch, M ;
Meydan, N ;
Andrews, D ;
Loubser, MD ;
Koren, G ;
Roifman, CM ;
Olivieri, NF .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (03) :597-600
[8]   IMMUNOLOGICAL PROFILE AFTER SPLENECTOMY IN CHILDREN WITH BETA-THALASSEMIA MAJOR [J].
MANDALENAKILAMBROU, K ;
VRACHNOU, E ;
CALOGEROPOULOU, C ;
LADIS, V ;
KATTAMIS, C .
ACTA HAEMATOLOGICA, 1987, 78 (04) :243-248
[9]  
QUINTILIANI L, 1983, B I SIEROTER MILAN, V62, P524
[10]  
SEN L, 1989, MEDICINA-BUENOS AIRE, V49, P131